Aspirin in combination with pancreatic cancer
Regular aspirin use may increase womens risk of developing pancreatic cancer, reports The Sun (October 28, 2003). The article appears on a poster presentation based. It is not possible to abstract the reliability of research results as the new version of the poster and press comment supply sufficiently detailed. The Sun reported that women who take an aspirin a day is an increased risk of deadly pancreatic cancer. The article appears on an abstract version of the press for poster presentation at the second annual International Conference on Frontiers in Cancer Prevention Research may be based.The study examined the relationship between aspirin and the development of pancreatic cancer among participants in the Nurses Health Study. Among the 88 378 women participating 161
cases of pancreatic cancer during 18 years of follow-up were documented. The study reveals that over a long duration of regular aspirin was associated with a significantly increased risk of pancreatic cancer. It is not possible, the research quality or reliability of the results as a poster and press release summary of sufficient detail for comment.Systematic reviews of personal information in the CRD searched for systematic reviews relevant to this issue. Systematic reviews are valuable sources of evidence to find, evaluate and synthesize all available data on a particular topic.